MSB
Click for more information
3.72% 97.5¢ mesoblast limited

Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-198

  1. eyeswideopen
    11,419 Posts.
    lightbulb Created with Sketch. 504
    clock Created with Sketch.
    12/11/20
    17:57
    Post #: 48834803
    The rerate should be extraordinary as not only does remestemcel-L for Covid ARDS need valuing by the market but Mesoblast entire portfolio as the first proves the science therefore likely success in all other indications!!
    MSB Price at posting: $3.20 Sentiment: Buy Disclosure: Not Held
    Likes Created with Sketch. 16  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.5¢ 		Change
0.035(3.72%) 		Mkt cap ! $1.110B
Open High Low Value Volume
94.0¢ 98.0¢ 92.0¢ $2.550M 2.663M

Buyers (Bids)

No. Vol. Price($)
20 111876 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 46145 13
View Market Depth
Last trade - 14.16pm 03/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.